Deutsche Bank 10/06/2010 1 Buy $48.50 44.7%
Target $48.50 (was $42.50). The broker expects the proposed merger with Lihir ((LGL)) will go ahead and as the combined group appears to match up well with other gold majors it retains its positive view on Newcrest.
Also supportive for the broker's Buy rating on the stock is that the Lihir proposal has caused Newcrest shares to underperform of late, which has improved the value on offer.
Target price is $48.50 Current Price is $33.50 Difference: $15
If NCM meets the Deutsche Bank target it will return approximately 45% (excluding dividends, fees and charges).
BA-Merrill Lynch 07/06/2010 1 Buy, Medium Risk $38.00 13.4%
No matter if you look at NCM from a play on gold perspective, from a relative perspective or as a standalone, Merrills says all the signs point to the same conclusion, Buy.
Macro factors are supporting the gold price, but NCM stands out by itself, the analysts add, also observing that it is trading below its peers.
Target price is $38.00 Current Price is $33.50 Difference: $4.5
If NCM meets the BA-Merrill Lynch target it will return approximately 13% (excluding dividends, fees and charges).
- Forums
- ASX - By Stock
- NCM
- deutsche bank $48.50 up 44.7%
deutsche bank $48.50 up 44.7%
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NCM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online